Announcements Trials
Browse Landscape

Status

Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Lymphoma, Non-Hodgkin 2Stomach Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Hodgkin Disease 1Glioblastoma 1Familial primary gastric lymphoma 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 3talimogene laherparepvec 2spartalizumab 1fludarabine 1atezolizumab 1aldesleukin 1TTI-621 1Radiation 1RXDX-106 1Proton Pump Inhibitors 1Nivolumab 1Ipilimumab 1Interleukin-2 1Injections, Subcutaneous 1In Situ Hybridization, Fluorescence 1Hydrocortisone 1Gemcitabine 1Cyclophosphamide 1Carboxylesterase 1Antineoplastic Protocols 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Proton Pump Inhibitors × Lymphoid × Clear all
NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡